# Carbamazepine ER

NDC: 72516-021
Generic name: Carbamazepine
Labeler / Manufacturer: Oryza Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260518

FDA application: ANDA212948

## Active ingredients

- CARBAMAZEPINE: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72516-021"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72516-021
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34b375d0-68b0-4bd5-8ac9-be043b57e91c